Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$4.4 - $9.28 $1.41 Million - $2.98 Million
-320,800 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$2.89 - $6.57 $927,112 - $2.11 Million
320,800 New
320,800 $1.71 Million

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About BriaCell Therapeutics Corp.


  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $11.8M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Cvi Holdings, LLC Portfolio

Follow Cvi Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cvi Holdings, LLC with notifications on news.